Medical Oncology Hematology Consultants Joins The US Oncology Network
Practice with largest infusion treatment center in Delaware gains access to world-class treatments and enhances its cutting-edge research program
Newark, Del. (March 1, 2017) – Medical Oncology Hematology Consultants (“MOHC”), the premier provider of advanced treatments for cancer and blood disorder patients in Delaware for more than 30 years, has joined The US Oncology Network (“The Network”), the largest network of its kind comprised of community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. The Network is supported by McKesson Specialty Health, an industry leader in solutions that empower the community patient care delivery system to advance the science, technology and quality of care. By joining The Network, MOHC enhances its ability to provide patients high-quality care as well as access to some of the most advanced oncology treatments available today, all delivered in convenient neighborhood locations close to the patient’s home.
“Our goal is to provide the best care available to our patients by utilizing technology on the cutting edge, but tempered with clinical judgement and compassion,” said David Biggs, MD, medical oncologist/hematologist and managing partner, MOHC. “We believe that joining The US Oncology Network will strengthen our ability to achieve this goal by helping us to retain our independence and strengthen our operational capabilities. The comprehensive resources and guidance from The Network will enhance our ability to work closely with our patients and their family physicians to provide high-quality medical care and personal attention.”
The US Oncology Network includes more than 1,400 highly-credentialed medical oncology, hematology, radiation oncology, gynecologic oncology, urology, oncology surgery and other specialists. The addition of MOHC extends the reach of The Network, broadening and strengthening the capabilities and knowledge-base of the organization throughout the region. The Network’s collaboration with McKesson Specialty Health provides strong and comprehensive practice management capabilities and value-based care expertise critical for community practices navigating today’s challenging healthcare landscape.
MOHC has a well-established clinical research program and is one of ten community oncology practices to have been selected for an American Society of Clinical Oncology (ASCO) Clinical Trials Participation Award. By uniting with The Network, the practice will have the ability to greatly increase the number and variety of novel clinical trials it can offer patients through US Oncology Research, a leader in bringing innovative therapies to patients in local communities across the nation. The organization manages approximately 300 active trials at any given time and has played a role in more than 60 FDA-approved cancer therapies, about one-third of all those approved by the FDA to date.
“Medical Oncology Hematology Consultants is an outstanding example of how independent community oncology practices can provide high-quality patient care and compete successfully in the rapidly evolving healthcare environment,” said Kirk Kaminsky, president of The US Oncology Network and Practice Management for McKesson Specialty Health. “The US Oncology Network is committed to providing practices like MOHC with innovative and comprehensive practice management solutions, allowing providers to overcome business challenges and ensure long-term practice health so the physicians can focus on their top priority – helping their patients fight cancer.”
About Medical Oncology Hematology Consultants
Medical Oncology Hematology Consultants (“MOHC”) specializes in the diagnosis and treatment of cancer, blood disorders, thrombosis and related genetic disorders. MOHC physicians, nurses, practitioners and office personnel work closely with patients and their family doctors to provide them with the best in medical care and personal attention. Medical Oncology Hematology Consultants is now located on the campus of the Christiana Hospital in the Helen F. Graham Cancer Center West. For more information, visit www.cbg.org.
About The US Oncology Network
Every day, The US Oncology Network (“The Network”) helps more than 1,400 independent physicians deliver value-based, integrated care for patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network provides doctors with access to coordinated resources, best business practices, and the experience, infrastructure and support of McKesson Specialty Health. This collaboration allows the doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. Together, The Network and its affiliated physicians are committed to the success of independent practices, everywhere. For more information, visit www.usoncology.com.